Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Antibody evolution from the centre to the periphery: applied to a human antibody fragment recognising the tumour-associated antigen mucin-1.

Author:
  • Pernilla Jirholt
  • Carl Borrebaeck
  • Mats Ohlin
Publishing year: 2002
Language: English
Pages: 407-416
Publication/Series: Journal of Molecular Biology
Volume: 318
Issue: 2
Document type: Journal article
Publisher: Elsevier

Abstract english

Mucin-1 has proven to be a suitable target for antibody-based diagnosis and therapy of certain tumours, but no appropriate human antibody or antibody fragment displaying slow dissociation rate kinetics against this target is available. Since a rapid dissociation character prevents an antibody fragment from remaining at the site of the antigen, this fact may prevent the successful application of a human mucin-1 specific antibody in diagnosis and therapy. We have now used iterative antibody libraries to evolve a human antibody fragment originally obtained from a naïve antibody library. A strategy was devised whereby molecular variants displaying slow dissociation kinetics against the repetitive mucin-1 tumour-associated antigen can be selected in vitro. The evolved clones, that allowed for a reduced dissociation from the tumour antigen, carried substitutions in the outer parts of the binding site. This demonstrated the ability of this in vitro evolution technique to mimic the process whereby antibodies evolve in vivo. We have thus devised a strategy through which molecular variants displaying slow dissociation from a repetitive target like the mucin-1 tumour-associated antigen can be obtained in vitro. These or related molecules obtained by this approach will serve as a starting point for the development of fully human antibodies for use in mucin-1 specific tumour therapy of diagnosis.

Keywords

  • Immunology in the medical area
  • Antibody Diversity
  • CA-15-3 Antigen : immunology
  • Complementarity Determining Regions
  • Evolution
  • Molecular
  • Protein Conformation
  • Neoplasms : therapy
  • Neoplasms : immunology
  • Neoplasms : diagnosis
  • Molecular Sequence Data
  • Models
  • Immunoglobulin Fragments : genetics
  • Human
  • Immunoglobulin Fragments : chemistry
  • Amino Acid Sequence

Other

Published
  • ISSN: 1089-8638
Carl Borrebaeck
E-mail: carl [dot] borrebaeck [at] immun [dot] lth [dot] se

Professor

Department of Immunotechnology

313k1

90

Director

Create Health

+46 46 222 96 13

313k1

90